Skip to Main Content

Author Details

Allison Welsh
Exact Sciences Corporation
2010
19
14
PMIDPaper TitleJournal TitlePublished Year
36556264Factors Likely to Affect the Uptake of Genomic Approaches to Cancer Screening in Primary Care: A Scoping Review.J Pers Med2022
30025711Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.Eur Urol Focus2020
32017048Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.Clin Pharmacol Ther2020
30368012Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung Cancer.J Thorac Oncol2019
30842242Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.Oncologist2019
30291913Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy.J Urol2019
29532557A prolonged response to platinum-based therapy in a patient with metastatic urothelial carcinoma harboring a single rearranged and truncated NF2 gene.Genes Chromosomes Cancer2018
29936259Analytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA.J Mol Diagn2018
29363525Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.Clin Cancer Res2018
27401243Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte Isolation.Clin Cancer Res2017
28187516Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.Clin Pharmacol Ther2017
27348626Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.Lab Invest2016
22820659Quantitative analysis of estrogen receptor expression shows SP1 antibody is more sensitive than 1D5.Appl Immunohistochem Mol Morphol2013
21980134Cytoplasmic estrogen receptor in breast cancer.Clin Cancer Res2012
22606272Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen.PLoS One2012
21709197Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells.J Clin Oncol2011
19337828Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines.Breast Cancer Res Treat2010
20359301Antibody validation.Biotechniques2010
20332259Analytic variability in immunohistochemistry biomarker studies.Cancer Epidemiol Biomarkers Prev2010
  • 1 - 19 of 19

Recommended Authors

Tom Baker Cancer Centre
Career Start Year 2012
Number of shared co-authors 1
University of Edinburgh
Career Start Year 2012
Number of shared co-authors 1
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 0
UCD Conway Institute, University College Dublin
Career Start Year 2007
Number of shared co-authors 0
University of British Columbia
Career Start Year 2007
Number of shared co-authors 2
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 3
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 2
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 4
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 4
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 3
University of British Columbia
Career Start Year 2000
Number of shared co-authors 0
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 2
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 1
University of British Columbia
Career Start Year 1994
Number of shared co-authors 2
Radboud University Medical Center
Career Start Year 1993
Number of shared co-authors 0
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 2
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 7
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 4
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 0
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 6
Buck Institute for Research on Aging
Career Start Year 1977
Number of shared co-authors 1
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 4
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 2

Collaborators

Yale University School of Medicine
Co-authored papers 7
Foundation Medicine
Co-authored papers 6
Foundation Medicine
Co-authored papers 5
Injury Prevention Research Center, University of North Carolina
Co-authored papers 5
University of Tubingen
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 2
Collegeville
Co-authored papers 2
Novartis Pharmaceuticals
Co-authored papers 2
Center for Devices and Radiological Health
Co-authored papers 2
Co-authored papers 2
Provista Diagnostics Inc.
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Center for Translational Data Science, University of Chicago
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 2
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 2
From Foundation Medicine
Co-authored papers 2
Illumina Inc.
Co-authored papers 2
Oncology Center of Excellence
Co-authored papers 2
Lineberger Comprehensive Cancer Center, University of North Carolina
Co-authored papers 2
Decipher Biosciences Inc.
Co-authored papers 2
Charite-University Hospital Berlin
Co-authored papers 2
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
University of Chicago
Co-authored papers 2
University of California San Diego Moores Cancer Center
Co-authored papers 2
Illumina Inc.
Co-authored papers 2
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers 2
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2